⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

HCA Healthcare HCA

United States Healthcare
5.5/10
AI Analyst score
435.61 USD
Last price at analysis date · analyst target 454.23 (+4.3%)
🛒 Where to buy HCAPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold: valuation is reasonable and growth is solid, but high debt and weakness in elective volumes limit upside potential.

HCA Healthcare is the largest hospital operator in the US, managing a network of hospitals and health centers, generating revenue from medical and surgical services. HCA Healthcare shows moderate financial health (5.16) with high debt (ND/EBITDA 3.20) and an attractive valuation (P/E 14.60), supported by revenue growth of 8.70% and earnings growth of 11.60%.

Financial health
5.2
Quality / Moat
5.0
Valuation
6.7
Growth
6.5
Dividend
3.4
Momentum
5.0
Risk & Context
5.3

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E14.60
Fwd P/E13.61
EV/EBITDA9.41
P/B-14.29
P/S1.24
PEG1.33
Market cap94.31 B USD
Enterprise value148.17 B USD
🏰 Quality and moat
ROIC (approx.)N/D
Gross margin42.58%
FCF conversion24%
Operating margin15.16%
📈 Profitability and margins
ROEN/D
ROA12.29%
Net margin8.77%
FCF3.74 B USD
FCF yield3.96%
🏦 Solvency and liquidity
Total debt51.55 B USD
Net debt50.42 B USD
Cash1.13 B USD
EBITDA15.75 B USD
Net debt / EBITDA3.20
D/EN/D
Current ratio0.99
Quick ratio0.78
🚀 Growth
Revenue growth8.70%
Earnings growth11.60%
EPS (TTM)29.84 USD
EPS (Fwd)32.02 USD
💰 Dividend and risk
Dividend yield0.72%
Payout10.1%
Beta1.11
Analyst consensusBuy (22)
Target price454.23 USD
52-week range353.99 USD – 556.52 USD
⚠️ Main risk: High debt (ND/EBITDA 3.20) and sensitivity to elective procedure demand are HCA's biggest risks, especially if interest rates remain high or demand weakens further.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

HCA Healthcare is the largest hospital operator in the US, managing a network of hospitals and health centers, generating revenue from medical and surgical services. HCA Healthcare shows moderate financial health (5.16) with high debt (ND/EBITDA 3.20) and an attractive valuation (P/E 14.60), supported by revenue growth of 8.70% and earnings growth of 11.60%.

Score by category

CategoryScore
Financial health5.2
Quality / Moat5.0
Valuation6.7
Growth6.5
Dividend3.4
Momentum5.0
Risk & Context5.3

OVERALL SCORE: 5.5/10

Context and risks

The US hospital sector faces regulatory pressure on pricing and labor costs, with moderate governance risk in the country. HCA's exposure to elective procedure volumes makes it sensitive to demand weakness, though there is no specific geopolitical or regulatory event directly affecting it.

News considered in the analysis

  • Can Community Health Sustain Growth as Elective Demand Softens? — La debilidad en la demanda de procedimientos electivos es un viento de frente sectorial que afecta a los volúmenes de HCA, aunque la noticia es especulativa y no aporta datos concretos de la empresa.
  • Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes? — La mención a menores volúmenes quirúrgicos es relevante para el sector hospitalario, pero se refiere a un competidor y no a HCA directamente; el impacto es indirecto y moderado.
  • Can HCA Sustain Earnings Growth Despite a Changing Service Mix? — La pregunta sobre la sostenibilidad del crecimiento de beneficios por el cambio en el mix de servicios es una preocupación válida, pero no aporta información nueva más allá de la incertidumbre ya conocida.
  • HCA Healthcare (HCA) Shares Moved, What Is Driving Attention Today? — Titular genérico sin información sustancial; no aporta datos relevantes para la valoración.
  • Can Pediatrix Sustain Growth Despite Lower Patient Volumes? — La debilidad en volúmenes de pacientes pediátricos es un riesgo sectorial, pero se refiere a otra empresa; el impacto en HCA es indirecto y limitado.

Verdict: Hold: valuation is reasonable and growth is solid, but high debt and weakness in elective volumes limit upside potential.

Main risk: High debt (ND/EBITDA 3.20) and sensitivity to elective procedure demand are HCA's biggest risks, especially if interest rates remain high or demand weakens further.

Other Healthcare companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.